Human Drugs View

Product Information
Registration Number DRP-9173-1
Generic Name Bortezomib
Brand Name Delexomib
Dosage Strength 3.5 mg
Dosage Form Lyophilized Powder for Injection (S.C./I.V.)
Classification Prescription Drug (Rx)
Pharmacologic Category Antineoplastic Agent (Proteasome Inhibitor)
Packaging Eu. Ph. Type I clear glass vial stoppered with 20 mm grey butyl rubber stopper, sealed with aluminum seal and red flip-off cap (Box of 1's)
Manufacturer Venus Remedies Ltd
Country of Origin India
Trader
Importer Aglobal Care, Inc
Distributor Delex Pharma International, Inc.
Application Type CLIDP Conversion
Issuance Date 19 May 2023
Expiry Date 25 September 2025